These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27636701)

  • 1. Neither vaginal nor buccal administration of 800 μg misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot study.
    Kalams SA; Rogers LM; Smith RM; Barnett L; Crumbo K; Sumner S; Prashad N; Rybczyk K; Milne G; Dowd SE; Chong E; Winikoff B; Aronoff DM
    Eur J Contracept Reprod Health Care; 2016 Dec; 21(6):436-442. PubMed ID: 27636701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misoprostol administered by epithelial routes: Drug absorption and uterine response.
    Meckstroth KR; Whitaker AK; Bertisch S; Goldberg AB; Darney PD
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):582-90. PubMed ID: 16946218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
    Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
    Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing vaginal and buccal misoprostol when used after methotrexate for early abortion.
    Wiebe ER; Trouton K
    Contraception; 2004 Dec; 70(6):463-6. PubMed ID: 15541407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of oral and vaginal misoprostol for cervical ripening before evacuation of first trimester missed miscarriage.
    Jabir M; Smeet RI
    Saudi Med J; 2009 Jan; 30(1):82-7. PubMed ID: 19139779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimester.
    Tang OS; Mok KH; Ho PC
    Hum Reprod; 2004 May; 19(5):1101-4. PubMed ID: 15070888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortion.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2004 Jan; 190(1):55-9. PubMed ID: 14749635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of misoprostol plasma concentrations following buccal and sublingual administration.
    Schaff EA; DiCenzo R; Fielding SL
    Contraception; 2005 Jan; 71(1):22-5. PubMed ID: 15639067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].
    Beucher G; Dolley P; Carles G; Salaun F; Asselin I; Dreyfus M
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):123-45. PubMed ID: 24433988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of buccal versus vaginal misoprostol for induction of second trimester abortion.
    Ellis SC; Kapp N; Vragpvoc O; Borgata L
    Contraception; 2010 May; 81(5):441-5. PubMed ID: 20399952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial.
    von Hertzen H; Piaggio G; Huong NT; Arustamyan K; Cabezas E; Gomez M; Khomassuridze A; Shah R; Mittal S; Nair R; Erdenetungalag R; Huong TM; Vy ND; Phuong NT; Tuyet HT; Peregoudov A;
    Lancet; 2007 Jun; 369(9577):1938-46. PubMed ID: 17560446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacology of misoprostol (pharmacokinetic data, adverse effects and teratogenic effects)].
    Aubert J; Bejan-Angoulvant T; Jonville-Bera AP
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):114-22. PubMed ID: 24440131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot study.
    Lohr PA; Reeves MF; Hayes JL; Harwood B; Creinin MD
    Contraception; 2007 Sep; 76(3):215-20. PubMed ID: 17707719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A crossover pharmacokinetic study of misoprostol by the oral, sublingual and buccal routes.
    Frye LJ; Byrne ME; Winikoff B
    Eur J Contracept Reprod Health Care; 2016 Aug; 21(4):265-8. PubMed ID: 27102981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual versus vaginal misoprostol for cervical ripening PRIOR TO manual vacuum aspiration under local anaesthesia: a randomized study.
    Caliskan E; Filiz T; Yucesoy G; Coskun E; Vural B; Corakci A
    Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):372-7. PubMed ID: 17853158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal misoprostol for cervical priming before dilatation and curettage in postmenopausal women: a randomized controlled trial.
    Bunnasathiansri S; Herabutya Y; O-Prasertsawat P
    J Obstet Gynaecol Res; 2004 Jun; 30(3):221-5. PubMed ID: 15210047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracervical sodium nitroprusside versus vaginal misoprostol in first trimester surgical termination of pregnancy: a randomized double-blinded controlled trial.
    Chan CC; Tang OS; Ng EH; Li CF; Ho PC
    Hum Reprod; 2005 Mar; 20(3):829-33. PubMed ID: 15608034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of misoprostol versus laminaria before dilation and evacuation in South Africa.
    Grossman D; Constant D; Lince-Deroche N; Harries J; Kluge J
    Contraception; 2014 Sep; 90(3):234-41. PubMed ID: 24929888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral versus vaginal misoprostol for cervical priming in first-trimester abortion: a randomized trial.
    Carbonell JL; Velazco A; Rodriguez Y; Tanda R; Sánchez C; Barambio S; Valera L; Chami S; Valero F; Aragón S; Marí J
    Eur J Contracept Reprod Health Care; 2001 Sep; 6(3):134-40. PubMed ID: 11763976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical softening with vaginal misoprostol before intrauterine device insertion.
    Li YT; Kuo TC; Kuan LC; Chu YC
    Int J Gynaecol Obstet; 2005 Apr; 89(1):67-8. PubMed ID: 15777909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.